Conventional therapy in psoriasis. Lost in translation?

As no more than one out of every 3 patients receiving a first course of acitretin, cyclosporin or fumaric acid esters achieved contemporary therapeutic objectives in psoriasis, biosimilars could be positioned as the first line of treatment in patients with moderate to severe psoriasis.